Tscan Therapeutics Inc
TCRX
$1.79-0.01 (-0.56%)
Aug 18, 2025, 3:22 PM
Financials
| 52Week High | 6.23 | 52Week Low | 1.02 |
| Beta | 1.06 | Current Ratio Annual | 8.14 |
| Current Ratio Quarterly | 7.06 | Market Cap | 101.86M |
| Net Profit Margin TTM | -1,964.88 | Operating Margin TTM | -2,087.73 |
| Price To Book | 0.58 | Price To Sales TTM | 14.63 |
| Quick Ratio Annual | 8.07 | Quick Ratio Quarterly | 6.96 |
| Return On Assets TTM | -40.51 | Return On Equity TTM | -63.84 |
| Return On Investment TTM | -55.59 | Revenue Growth3Y | -34.76 |
| Revenue Growth Quarterly Yoy | 473.88 | Revenue Growth TTMYoy | -42.96 |
| Revenue Per Share TTM | 0.05 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 92 | 0 | 1 | 3 | 2 | 2 | 41.54M | $125.95M |
| Mar 31, 2025 | 92 | 15(+%) | 13(+1200%) | 33(+1000%) | 19(+850%) | 22(+1000%) | 40.13M(-3%) | $55.14M(-56%) |
| Jun 30, 2025 | 79(-14%) | 16(+7%) | 32(+146%) | 24(-27%) | 18(-5%) | 15(-32%) | 34.86M(-13%) | $50.41M(-9%) |